Area of research
Public Health, Environmental and Occupational Health · Applied Microbiology and Biotechnology
Research interest
Research interests include Mosquito-borne diseases and control, Malaria Research and Control, Antibiotic Use and Resistance, and Vector-borne infectious diseases.
Cross-sectional evaluation of host biomarkers for guiding antibiotic use in bacterial and non-bacterial acute febrile illness in low- and middle-income tropical settings
Cross-sectional evaluation of host biomarkers for guiding antibiotic use in bacterial and non-bacterial acute febrile illness in low- and middle-income tropical settings.
Serological diagnosis of strongyloidiasis: An evaluation of three commercial assays
Identification of <i>Burkholderia cepacia</i> strains that express a <i>Burkholderia pseudomallei</i> -like capsular polysaccharide
Evaluation of a point-of-care multiplex immunochromatographic assay for the diagnosis of typhoid: results from a retrospective diagnostic accuracy study
The Impacts of Climate Change on the Emergence and Reemergence of Mosquito-Borne Diseases in Temperate Zones: An Umbrella Review Protocol.
Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions
Impact of the Introduction of a Package of Diagnostic Tools, Diagnostic Algorithm, and Training and Communication on Outpatient Acute Fever Case Management at 3 Diverse Sites in Uganda: Results of a Randomized Controlled Trial
Synthesis and Meta-analysis of 3 Randomized Trials Conducted in Burkina Faso, Ghana, and Uganda Comparing the Effects of Point-of-Care Tests and Diagnostic Algorithms Versus Routine Care on Antibiotic Prescriptions and Clinical Outcomes in Ambulatory Patients &lt;18 Years of Age With Acute Febrile Illness
Advancing Access to Diagnostic Tools Essential for Universal Health Coverage and Antimicrobial Resistance Prevention: An Overview of Trials in Sub-Saharan Africa
Missed opportunities for integrated testing of HIV and tuberculosis on the GeneXpert platform in Lesotho.
Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid test
The impact of C-reactive protein testing on treatment-seeking behavior and patients' attitudes toward their care in Myanmar and Thailand.
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
Antibody tests for identification of current and past infection with SARS-CoV-2
Performance and utility of more highly sensitive malaria rapid diagnostic tests
Comparative Analysis of Commercially Available Typhoid Point-of-Care Tests: Results of a Prospective and Hybrid Retrospective Multicenter Diagnostic Accuracy Study in Kenya and Pakistan
Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings
Antimicrobial resistance patterns in bacteria causing febrile illness in Africa, South Asia, and Southeast Asia: a systematic review of published etiological studies from 1980-2015
Addressing the diagnostic gap in hypertension through possible interventions and scale-up: A microsimulation study
Host Biomarkers Reflect Prognosis in Patients Presenting With Moderate Coronavirus Disease 2019: A Prospective Cohort Study
Evaluations of training and education interventions for improved infectious disease management in low-income and middle-income countries: a systematic literature review.
Two-test algorithms for infectious disease diagnosis: Implications for COVID-19.
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
Anticipating the future: prognostic tools as a complementary strategy to improve care for patients with febrile illnesses in resource-limited settings.
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease
Routine laboratory testing to determine if a patient has COVID-19
The good and the bad: using C reactive protein to distinguish bacterial from non-bacterial infection among febrile patients in low-resource settings.